Budd-Chiari syndrome: A single-center experience

Table 4 Characteristics of patients who died after diagnosis of Budd-Chiari syndrome

Study ID	Age at death	Gender	Race	Ethnicity	Evaluated for LT? (Y/N)	Listed for LT? (Y/N)	Contraindication for LT? (Y/N) If “Yes,” specify	Time from listing to death (mo)	LT?(Y/N)	Cause of death
1	49	F	Black or AA	Not hispanic or Latino	Y	Y	N	26	N	Unknown
2	61	M	White	Not hispanic or Latino	N	N	Y; HCC with extensive vascular invasion and lung metastasis	N/A	N	Unknown
3	49	M	White	Not hispanic or Latino	Y	Y	N	65	N	Metastatic colon cancer
4	59	M	White	Not hispanic or Latino	Y	N	Y; poor LT candidate due to ESRD, history of CAD, and kidney/pancreas transplant	N/A	N	Vertebral osteomyelitis of the lumbar spine, MRSA bacteremia
5	34	M	White	Not hispanic or Latino	Y	Y	Y; Testicular cancer	12	N	Metastatic testicular cancer
6	34	M	White	Not hispanic or Latino	Y	Y	N	72	N	Hypercapnic respiratory failure, pneumonia
7	67	F	Black or AA	Not hispanic or Latino	Y	N	N (in transplant evaluation stage at date of death)	N/A	N	Severe sepsis
8	52	F	Other	Not hispanic or Latino	Y	N	Y; HCC with secondary malignant neoplasm of the lung	N/A	N	Liver failure, metastatic HCC
9	42	F	White	Not hispanic or Latino	N	N	Y; Breast cancer	N/A	N	Metastatic breast cancer
10	69	M	White	Not hispanic or Latino	Y	Y	N	16	N	Renal failure, liver failure, possible sepsis

LT: Liver transplantation; AA: African American; HCC: Hepatocellular carcinoma; CAD: Coronary artery disease; ESRD: End-stage renal disease; MRSA: Methicillin-resistant Staphylococcus aureus; F: Female; M: Male; Y/N: Yes/No; N/A: Not available.